← Leaderboards
John Lee
University Of Pennsylvania
$3,280,818
Attributed
$3,280,818
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2005–19$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$3,280,818 · 2
By mechanism
R44$2,795,038 · 1
K08$485,780 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Mitchell A. Lazar$48,884,193
- Aimee S Payne$10,136,122
- Bonnie Ky$11,886,775
- Mark L Kahn$46,704,160
- John R Stanley$7,319,814
Others in their field
Top investigators on “Hemodynamics”
- Alan Jasanoff · Massachusetts Institute Of Technology$22,516,687
- Jay D Humphrey · Yale University$22,350,674
- Angela L. Jefferson · Vanderbilt University Medical Center$21,651,697
- Robert Freedman · University Of Colorado Denver$20,038,696
- Danny Bluestein · State University New York Stony Brook$18,226,851
- Kent A Kiehl · Hartford Hospital$17,001,778
Research focus
HemodynamicsAnti-InflammatoryNovel TherapeuticsPhysiologicalAdultBiologicalClinical ResearchIn VivoSiteSeveritiesAntibodiesAreaArterial Fatty StreakArterial RemodelingApolipoprotein EAnalogAdverse EventAortaBlood PressureBlood FlowBlood VesselsBos TaurusCaliberAnti-Inflammatory Agents
Grant awards (7)
Safety, tolerability and efficacy of a novel sustained release analog of vasoactive intestinal peptide, PB1046, in patients with pulmonary arterial hypertension$1,249,307
R44 · FY2019 · HL · contact PI
Safety, tolerability and efficacy of a novel sustained release analog of vasoactive intestinal peptide, PB1046, in patients with pulmonary arterial hypertension$1,247,966
R44 · FY2018 · HL · contact PI
Safety, tolerability and efficacy of a novel sustained release analog of vasoactive intestinal peptide, PB1046, in patients with pulmonary arterial hypertension$297,765
R44 · FY2018 · HL · contact PI
LKLF and vascular responses to hemodynamic shear in vivo$85,964
K08 · FY2008 · HL · contact PI
LKLF and vascular responses to hemodynamic shear in vivo$133,272
K08 · FY2007 · HL · contact PI
LKLF and vascular responses to hemodynamic shear in vivo$133,272
K08 · FY2006 · HL · contact PI
LKLF and vascular responses to hemodynamic shear in vivo$133,272
K08 · FY2005 · HL